Aims Resveratrol is a polyphenolic compound that has received much attention for its use in
ameliorating various systemic pathological conditions. The present study was performed to …

Numerous epidemiological studies have demonstrated that approximately 40% of
myocardial infarctions (MI) are associated with heart failure (HF). Resveratrol, a naturally …

Background Cardiac hypertrophy is a compensatory stage of the heart in response to stress
such as pressure overload (PO), which can develop into heart failure (HF) if left untreated …

Oxidative stress induced by free fatty acid aggravates endothelial injury, which leads to
diabetic cardiovascular complications. Reduction of intracellular oxidative stress may …

Background/Aims: Low ambient temperature is an important risk factor for cardiovascular
diseases, and has been shown to lead to cardiac hypertrophy. In this study, we aim to …

Resveratrol is a kind of iPolyphenols widely existing in herbal medicine. Here we aim to
investigate whether resveratrol can reduce the degree of myocardial ischemia/reperfusion …

Despite great advances in therapies observed during the last decades, heart failure (HF)
remained a major health problem in western countries. In order to further improve symptoms …

Background Resveratrol is a Sirt-1-specific activator, which also exerts cardioprotective
effects that regulate redox signalling during oxidative stress and autophagy during …

Recent data show that cardiac hypertrophy contributes substantially to the overall heart
failure burden. Mitochondrial dysfunction is a common feature of cardiac hypertrophy …

Background/Aims: Resveratrol (Res), a polyphenol antioxidant found in red wine, has been
shown to play a cardioprotective role. This study was undertaken to investigate whether Res …